Kymera Therapeutics is Named one of the FierceBiotech's Fierce 15 Companies of 2019
Por um escritor misterioso
Descrição
/PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines
Small molecule approaches to treat autoimmune and inflammatory
ny20007125x500_image020.jpg
SEC Filing Kymera Therapeutics, Inc.
FierceBiotech names Frontier Medicines one of its Fierce 15
Targeted protein degradation: a new pharmacology paradigm?
Matthew Weiss on LinkedIn: Awesome to be part of the fantastic
SEC Filing - Prelude Therapeutics
ny20007125x500_image028.jpg
FIERCE 15 Fierce Biotech Summit
The top 10 best-paying places to work in biopharma
SEC Filing — Vigil Neuroscience, Inc
de
por adulto (o preço varia de acordo com o tamanho do grupo)
